Diabetic Nephropathy - Boner Flashcards
Definitions of albuminuria
Definitions: Normal urine albumin: <30 mg/day
Microalbuminuria 30-300mg/day
Macroalbuminuria >300mg/day=proteinuria >500mg/day
Stages in diabetic renal disease
- Hyperfiltration and nephromegaly
- Normoalbuminuria, mild path changes GFR normal (progressing, early on hyperfiltration)
- Microalbuminuria, Incipient DN, GFR normal in type one but decreased in type 2
- Macroalbuminuria or overt DN decreased GFR
- ESRD (80% of type I and 50-80% of type II because die of CV causes more often)
Albumin excretion rate increases very quickly as diabetes progresses. BP increases but at a slower rate.
Type II has more quick deterioration than type I.
Pathology of Diabetic Nephropathy
Thickening of glomerular basement membrane (GBM) and tubular basement membrane – early changes
Arteriolar hyalinosis and subendothelial accumulation of hyaline in the glomerular capillaries – 3-5 years after onset of diabetes
Increase in the fractional volume of mesangial matrix and mesangium per glomerulus – 4-5 years after onset of type 1 diabetes
Tubular hypertrophy
Diffuse diabetic glomerulosclerosis, widespread mesangial expansion within and among glomeruli
Nodular glomerulosclerosis (Kimmelstiel-Wilson nodules), segmental expansion of mesangium appearing as round fibrillar nodules – usually in proteinuria with established diabetic nephropathy
Mechanisms of effects of angiotensin II
Hemodynamic effects
Systemic hypertension
Systemic & renal vasoconstriction
Stimulation of other vasoconstrictors & inhibition of vasodilators
Increased glomerular capillary pressure and permeability
Mesangial cell contraction leading to reduction in filtration surface area
Nonhemodynamic effects
Induction of renal hypertrophy and cell proliferation
Stimulation of extracellular matrix (ECM) synthesis
Inhibition of ECM degradation
Stimulation of cytokine production
Stimulation of superoxide production
Activation of nuclear factor – κB
Reduction in podocyte nephrin expression
Factors influencing development and Progression of Diabetic nephropathy
Prevention strategies
Glycemic control and Duration of Disease
Increased Urine Albumin excretion at presentation
Hypertension and Family history of hypertension
Genetic factors
Smoking
Dyslipidemia
Male gender
Advancing age (type 2)
Good control of hyperglycemia (target HbA1c < 7.0%)
Maintain normotension as low as tolerated with a regimen that includes an ACE-inhibitor or AT1-receptor antagonist
Salt restriction (<6 g/d) and reduced protein intake (0.8 - 1.0 g/ kg body weight/ day
Cessation of smoking
Administration of statins
Weight loss (if obese), light regular aerobic exercise
Avoid use of minor analgesics
Avoid nephrotoxic medications (contrast media, antibiotics, nonsteroidals)